Spinal analgesic actions of the new endogenous opioid peptides endornorphin-1 and -2

NeuroReport

Volumn 8, Issue 14, 1997, Pages 3131-3135

  Stone, Laura S ^a   Fairbanks, Carolyn A ^a   Laughlin, Tinna M ^a   Nguyen, H Oanh ^a   Bushy, Tina M ^a   Wessendorf, Martin W ^a   Wilcox, George L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Allodynia; Autinociception; Dynorphin; Endomorphin; Intrathecal; Mice; Opioid; Subst ance P; Tall flick; Tolerance

Indexed keywords

DYNORPHIN A; ENDOMORPHIN 1; ENDOMORPHIN 2; ENDORPHIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE PEPTIDE; SUBSTANCE P; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

EID: 0030863633     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199709290-00025     Document Type: Article

References (13)

1. Yaksh TL and Rudy TA. J Pharmacol Exp Ther 202, 411-428 (1977).
2. Zadina JE, Hackler L, Ge LJ et al. Nature 386, 499-502 (1997).
3. Hylden JLK and Wilcox GL. Eur J Pharmacol 67, 313-316 (1980).
4. Wigdor S and Wilcox GL. J Pharmacol Exp Ther 242, 90-95 (1987).
5. Janssen PA, Niemegeers CJE and Dony JGH. Arzneim Forsch 13, 502-507 (1963).
6. Hylden JLK and Wilcox GL. Brain Res 217, 212-215 (1981).
7. Vanderah T, Laughlin T, Lashbrook JM et al. Pain 68, 275-281 (1996).
8. Laughlin T, Vanderah T, Lashbrook JM et al. Pain (in press).
9. Tallarida R and Murray R. Manual of Pharmacological Calculations with Computer Programs. New York: Springer Verlag, 1987.
10. Wu HH, Lester BR, Sun Z et al. Pain 56, 203-210 (1994).
11. Wilcox GL. Ann NY Acad Sci 525, 228-236 (1988).
12. Fairbanks CA and Wilcox GL. J Pharmacol Exp Ther, in press.
13. Hylden JLK and Wilcox GL. J Pharmacol Exp Ther 226, 398-404 (1983).